← back to search

Kamila Czene

Karolinska Institutet · SE
Area of research
Genetics · Cancer Research
Research interest
Research interests include BRCA gene mutations in cancer, Breast Cancer Treatment Studies, Digital Radiography and Breast Imaging, and Cancer Risks and Factors.
h-index
90
citations
35,549
works
741
NIH funding
primary concept
email

Recent publications

Mammographic density, pathogenic breast cancer susceptibility gene variants and breast cancer risk
medRxiv 2025cited by 0position: middledoi
Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction
medRxiv 2024cited by 10position: middledoi
Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing dataset
The American Journal of Human Genetics 2024cited by 8position: middledoi
Publisher Correction: Understanding the genetic complexity of puberty timing across the allele frequency spectrum
Nature Genetics 2024cited by 3position: middledoi
Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification
medRxiv 2024cited by 3position: middledoi
Germline copy number variants and endometrial cancer risk
Human Genetics 2024cited by 2position: middledoi
Analysis of variants in untranslated and promoter regions and breast cancer risk using whole genome sequencing data
medRxiv 2024cited by 1position: middledoi
Clinical biomarker-based biological aging and risk of cancer in the UK Biobank
British Journal of Cancer 2023cited by 149position: middledoi
Evaluation of circulating plasma proteins in breast cancer using Mendelian randomisation
Nature Communications 2023cited by 48position: middledoi
Long-Term Performance of an Image-Based Short-Term Risk Model for Breast Cancer
Journal of Clinical Oncology 2023cited by 41position: middledoi
Side effects of low-dose tamoxifen: results from a six-armed randomised controlled trial in healthy women
British Journal of Cancer 2023cited by 31position: middledoi
The impact of coding germline variants on contralateral breast cancer risk and survival
The American Journal of Human Genetics 2023cited by 26position: middledoi
Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival
Journal of Clinical Oncology 2023cited by 26position: middledoi
Breast Cancer Incidence After a False-Positive Mammography Result
JAMA Oncology 2023cited by 24position: lastdoi
FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women
European Journal of Human Genetics 2023cited by 13position: middledoi
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry
Breast Cancer Research 2023cited by 11position: middledoi
Association of the <scp> <i>CHEK2</i> </scp> c. <scp>1100delC</scp> variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival
Cancer Medicine 2023cited by 10position: middledoi
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants
npj Breast Cancer 2023cited by 7position: middledoi
A Likelihood Ratio Approach for Utilizing Case-Control Data in the Clinical Classification of Rare Sequence Variants: Application to BRCA1 and BRCA2
Human Mutation 2023cited by 6position: middledoi
Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancer
European Journal of Epidemiology 2023cited by 6position: middledoi
Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel
Journal of Medical Genetics 2023cited by 5position: middledoi
Understanding the genetic complexity of puberty timing across the allele frequency spectrum
medRxiv 2023cited by 5position: middledoi
Prediction of breast cancer risk for sisters of women attending screening
JNCI Journal of the National Cancer Institute 2023cited by 2position: lastdoi
Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases
Cancers 2023cited by 1position: middledoi
Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes
JAMA Oncology 2022cited by 184position: middledoi
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study
British Journal of Sports Medicine 2022cited by 96position: middledoi
Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study
Journal of Medical Genetics 2022cited by 95position: middledoi
Breast cancer risks associated with missense variants in breast cancer susceptibility genes
Genome Medicine 2022cited by 54position: middledoi
Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies
JNCI Journal of the National Cancer Institute 2022cited by 50position: middledoi
A risk model for digital breast tomosynthesis to predict breast cancer and guide clinical care
Science Translational Medicine 2022cited by 35position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Per Hall · Karolinska Institutet38 papers (2012–2023)Mikael Eriksson · Skåne University Hospital23 papers (2014–2023)Keith Humphreys · Karolinska Institutet13 papers (2012–2023)Jingmei Li · Agency for Science, Technology and Research12 papers (2012–2019)Marike Gabrielson · Karolinska Institutet6 papers (2016–2023)Douglas F. Easton · Pacific Biomarkers (United States)6 papers (2018–2023)Louise Eriksson · Saint Göran Hospital6 papers (2012–2018)Linda S. Lindström · Uppsala University6 papers (2017–2023)Lorelei A. Mucci · American Cancer Society5 papers (2014–2017)Jennifer R. Harris · Cleveland Clinic5 papers (2014–2017)­Eero Pukkala · Cancer Registry of Norway5 papers (2014–2017)Jonas Bergh · Karolinska Institutet5 papers (2012–2019)Wei He · Lishui University5 papers (2015–2023) · 5 papers (2014–2017)José Tapia · Karolinska Institutet5 papers (2016–2023)Jaakko Kaprio · Institute for Molecular Medicine Finland (FIMM)5 papers (2014–2017) · 5 papers (2014–2017)Hans‐Olov Adami · Oslo University Hospital5 papers (2014–2017) · 4 papers (2014–2018)Martin Eklund · Karolinska Institutet4 papers (2015–2023)